Integra LifeSciences Holdings Corporation (IART)
NASDAQ · Healthcare
Integra LifeSciences Holdings Corporation Shareholder Equity 2016–2025
Integra LifeSciences Holdings Corporation annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Integra LifeSciences Holdings Corporation shareholder equity as of December 31, 2025: 1.04B, a 32.47% decrease year-over-year.
- Integra LifeSciences Holdings Corporation shareholder equity for 2025 were 1.04B, a 32.47% decrease from 2024.
- Integra LifeSciences Holdings Corporation shareholder equity for 2024 were 1.55B, a 2.68% decrease from 2023.
- Integra LifeSciences Holdings Corporation shareholder equity for 2023 were 1.59B, a 12.00% decrease from 2022.
- Integra LifeSciences Holdings Corporation shareholder equity for 2022 were 1.80B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Integra LifeSciences Holdings Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,043 |
| 2024 | $1,545 |
| 2023 | $1,588 |
| 2022 | $1,804 |
| 2021 | $1,685 |
| 2020 | $1,515 |
| 2019 | $1,417 |
| 2018 | $1,376 |
| 2017 | $962 |
| 2016 | $840 |
Integra LifeSciences Holdings Corporation Shareholder Equity — FAQ
Integra LifeSciences Holdings Corporation (IART) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IART's shareholder equity history?
The chart and table above show Integra LifeSciences Holdings Corporation's shareholder equity by year and by quarter, including the growth rate.